CJC-1295 (No DAC) and Ipamorelin are a complementary peptide blend that stimulates the pituitary gland to naturally produce and pulse Growth Hormone (GH). Users typically combine them to support lean muscle growth, improve fat metabolism, enhance sleep quality, and accelerate workout recovery.
How the Combination WorksCJC-1295 (No DAC): Acts as a Growth Hormone-Releasing Hormone (GHRH) mimic. The “No DAC” (Drug Affinity Complex) version prevents the peptide from binding to blood proteins, keeping its half-life shorter (around 30 to 60 minutes). This allows for natural, pulsatile bursts of GH rather than a sustained, unnatural trickle.
Ipamorelin: Acts as a ghrelin receptor agonist. It works synergistically with CJC to trigger a stronger, immediate release of GH. Unlike older peptides (like GHRP-6), it does not significantly increase hunger or spike cortisol and prolactin levels.
Commonly Discussed DosingBecause dosing varies widely depending on individual goals, most practitioners recommend following personalized clinical protocols. Typical discussions revolve around the following parameters:
Ratio: Usually combined in a 1:1 or 1:2 ratio (e.g., 100 mcg to 200 mcg of each).Frequency: Injections are commonly self-administered subcutaneously once or twice daily, often before bed to align with natural sleep-cycle GH pulses.
Common Side EffectsWhile generally well-tolerated, potential side effects and risks associated with growth hormone secretagogues include:
Injection site reactions (pain, redness, or swelling)Mild fluid retention or joint stiffnessHeadaches or dizziness in rare casesFor a detailed breakdown of benefits, safety profiles, and mechanisms, you can refer to the comprehensive Innerbody CJC-1295 and Ipamorelin Guide or the BOC Sciences CJC-1295 Overview.




Reviews
There are no reviews yet.